Showing results (561-570 of 1,023) with videos related to
Sort By:
Pageof 103
Archives of Biochemistry and Biophysics|July 1, 1993
Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins)M Hiraiwa, J S O'Brien, Y Kishimoto, et al.Leukemia & Lymphoma|March 18, 2000
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemiaM J Keating, T L Smith, S Lerner, et al.Cancer|March 4, 2000
ATM gene deletion in patients with adult acute lymphoblastic leukemiaM A Haidar, H Kantarjian, T Manshouri, et al.Cancer Research|October 27, 1998
Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemiaP Starostik, T Manshouri, S O'Brien, et al.Implementation Science Communications|January 17, 2025
Designing an intervention to improve cognitive evaluations in primary careKyra S O'Brien, Kristin Harkins, MaryAnne Peifer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Second cancer risk in hairy cell leukemia: analysis of 350 patientsR Kurzrock, S S Strom, E Estey, et al.Pain|October 12, 2007
Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based studyB I Nicholl, S L Halder, G J Macfarlane, et al.Particle and Fibre Toxicology|October 4, 2017
In vitro toxicoproteomic analysis of A549 human lung epithelial cells exposed to urban air particulate matter and its water-soluble and insoluble fractionsNgoc Q Vuong, Dalibor Breznan, Patrick Goegan, et al.Journal of Biomolecular NMR|August 4, 2018
Improving yields of deuterated, methyl labeled protein by growing in H2OEvan S O'Brien, Danny W Lin, Brian Fuglestad, et al.The American Journal of Medicine|February 1, 1991
Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemiaH M Kantarjian, C Childs, S O'Brien, et al.Pageof 103